SELECTION OF OPTIMIZED NANO EMULSION FORMULATION CONTAINING CURCUMINE
About this article
Received: 27/12/19                Revised: 13/01/20                Published: 11/06/20Abstract
Curcumin is a natural active composition used for effection and cancer, however, it has low bioavailability because of its dissolution in water in oral route, with its advantages that are easier to prepare, more stable, and small size of droplet, the nanoemulsion easily go through intestinal walls into blood and the bioavailability of curcumin in oral route could be improved. Base on recent results of the effective factors on droplet sizes of nanoemulsion, MODDE and Inform were used to optimize the formulation of curcumin nanoemulsion. Nanoemulsion comprising curcumin was prepared with an emulsion method with supporting high-speed homogenizer and ultrasound waves. The size of droplets and stability were evaluated by the micro crops method. The results showed that drops size of nanoemulsion was clearly affected by the amount of Tween 80 but not by amount of polyethylene glycol 400 that had almost effected on stability. So that the formulation of nanoemulsion containing curcumin was optimized and chosen.
Keywords
Pharmacy; nano emulsion; curcumine; tween; optimation.
Full Text:
PDF (Tiếng Việt)References
[1]. R. A. Sharma, A. J. Gescher, and W. P. Steward, "Curcumin: The story so far," European Journal of Cancer, vol. 41, no. 13, pp. 1955-1968, 2005.
[2]. P. Anand, A. B. Kunnumakkara, and R. A. Newman, "Bioavailability of curcumin: problems and promises," Molecular pharmaceutics, vol. 4, no. 6, pp. 807-818, 2007.
[3]. C. S. Beevers, and S. Huang, "Pharmacological and clinical properties of curcumin," Botanics: Targets and Therapy, vol. 1, pp. 5-18, 2011.
[4]. Q. Huang, H. Yu, and Q. Ru, "Bioavailability and delivery of nutraceuticals using nanotechnology," Journal of Food Science, vol. 75, pp. 50-57, 2011.
[5]. A. Kumar, A. Ahuja, and J. Ali, "Curcumin-loaded lipid nanocarrier for improving bioavailability. stability and cytotoxicity against malignant glioma cells," Drug Delivery, vol. 23, no. 1, pp. 214-229, 2014.Refbacks
- There are currently no refbacks.





